Scotiabank Predicts Stronger Earnings for SNC-Lavalin Group

SNC-Lavalin Group Inc. (TSE:ATR) – Research analysts at Scotiabank increased their FY2025 earnings estimates for SNC-Lavalin Group in a research note issued on Friday, January 23rd. Scotiabank analyst J. Goldman now forecasts that the company will earn $3.76 per share for the year, up from their previous forecast of $3.57.

SNC-Lavalin Group Price Performance

About SNC-Lavalin Group

AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions.